Man Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-56,292
Closed -$404K 2518
2025
Q4
$404K Buy
56,292
+26,155
+87% +$207K ﹤0.01% 1942
2025
Q3
$322K Sell
30,137
-38,081
-56% -$374K ﹤0.01% 1979
2025
Q2
$660K Buy
+68,218
New +$704K ﹤0.01% 1741
2025
Q1
Sell
-91,792
Closed -$1.37M 2308
2024
Q4
$1.37M Sell
91,792
-39,645
-30% -$646K ﹤0.01% 1410
2024
Q3
$2.51M Buy
131,437
+14,733
+13% +$305K 0.01% 1242
2024
Q2
$2.42M Buy
116,704
+84,328
+260% +$1.68M 0.01% 1287
2024
Q1
$609K Buy
32,376
+2,224
+7% +$38.2K ﹤0.01% 1721
2023
Q4
$435K Buy
+30,152
New +$410K ﹤0.01% 1721
2023
Q3
Sell
-402,723
Closed -$8.4M 1346
2023
Q2
$8.38M Buy
+402,723
New +$8.75M 0.03% 683
2022
Q2
Sell
-82,416
Closed -$2.88M 2308
2022
Q1
$2.88M Buy
82,416
+46,704
+131% +$1.6M 0.01% 1099
2021
Q4
$1.09M Buy
35,712
+10,469
+41% +$341K ﹤0.01% 1315
2021
Q3
$828K Buy
25,243
+10,420
+70% +$333K ﹤0.01% 1390
2021
Q2
$448K Buy
+14,823
New +$488K ﹤0.01% 1591

Other funds holding OGN

Man Group's OGN Position: Q1 2026 in Review

Man Group sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 56,292 shares — an estimated $404K sold.

Man Group first reported a position in OGN in Q2 2021 and held it in 13 quarters. The position peaked at $8.38M in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Man Group reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Man Group sold 56,292 Organon & Co shares in Q1 2026, an estimated $404K.
  • Man Group first reported a position in Organon & Co in Q2 2021 and held it in 13 quarters.
  • Man Group's Organon & Co position peaked at $8.38M in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.